Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug testing and analysis

Showing results (461-470 of 2,766) with videos related to

Pageof 277
Sort By:
Drug Testing and Analysis|March 7, 2019
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogsSamuel D Banister, Richard C Kevin, Lewis Martin, et al.
Drug Testing and Analysis|March 6, 2019
Beta<sub>2</sub> -adrenergic ligand racemic formoterol exhibits enantioselective disposition in blood and skeletal muscle of humans, and elicits myocellular PKA signaling at therapeutic inhaled dosesMorten Hostrup, Christian K Narkowicz, Sajad Habib, et al.
Drug Testing and Analysis|February 28, 2017
Analysis of drugs of abuse in Cerumen - correlation of postmortem analysis results with those for blood, urine and hairSylvia I Meier, Sarah C Koelzer, Manfred Schubert-Zsilavecz, et al.
Drug Testing and Analysis|December 27, 2016
Evaluation of KIMS immunoassays on a cobas c 501 analyzer for drugs of abuse and ethyl glucuronide testing in urine for forensic abstinence controlMerja A Neukamm, Arsham Bahrami, Volker Auwärter, et al.
Drug Testing and Analysis|February 17, 2017
Increasing the linear dynamic range in LC-MS: is it valid to use a less abundant isotopologue?Stephen Trobbiani, Peter Stockham, Timothy Scott
Drug Testing and Analysis|April 2, 2019
Evaluation of sulfate metabolites as markers of intramuscular testosterone administration in Caucasian and Asian populationsArgitxu Esquivel, Élida Alechaga, Nuria Monfort, et al.
Drug Testing and Analysis|August 20, 2019
Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein bindingTanja M Gampfer, Lilian H J Richter, Jan Schäper, et al.
Drug Testing and Analysis|August 28, 2019
Detection of testosterone doping in female athletesDavid J Handelsman, Stéphane Bermon
Drug Testing and Analysis|March 24, 2017
'APAAN in the neck' - A reflection on some novel impurities found in seized materials containing amphetamine in Ireland during routine forensic analysisJohn D Power, Pierce Kavanagh, Gavin McLaughlin, et al.
Drug Testing and Analysis|March 26, 2017
Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS<sup>n</sup> , and LC-HR-MS/MSAchim T Caspar, Jonas B Gaab, Julian A Michely, et al.
Pageof 277

Showing results (461-470 of 2,766) with videos related to

Sort By:
Pageof 277
Drug Testing and Analysis|March 7, 2019
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogsSamuel D Banister, Richard C Kevin, Lewis Martin, et al.
Drug Testing and Analysis|March 6, 2019
Beta<sub>2</sub> -adrenergic ligand racemic formoterol exhibits enantioselective disposition in blood and skeletal muscle of humans, and elicits myocellular PKA signaling at therapeutic inhaled dosesMorten Hostrup, Christian K Narkowicz, Sajad Habib, et al.
Drug Testing and Analysis|February 28, 2017
Analysis of drugs of abuse in Cerumen - correlation of postmortem analysis results with those for blood, urine and hairSylvia I Meier, Sarah C Koelzer, Manfred Schubert-Zsilavecz, et al.
Drug Testing and Analysis|December 27, 2016
Evaluation of KIMS immunoassays on a cobas c 501 analyzer for drugs of abuse and ethyl glucuronide testing in urine for forensic abstinence controlMerja A Neukamm, Arsham Bahrami, Volker Auwärter, et al.
Drug Testing and Analysis|February 17, 2017
Increasing the linear dynamic range in LC-MS: is it valid to use a less abundant isotopologue?Stephen Trobbiani, Peter Stockham, Timothy Scott
Drug Testing and Analysis|April 2, 2019
Evaluation of sulfate metabolites as markers of intramuscular testosterone administration in Caucasian and Asian populationsArgitxu Esquivel, Élida Alechaga, Nuria Monfort, et al.
Drug Testing and Analysis|August 20, 2019
Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein bindingTanja M Gampfer, Lilian H J Richter, Jan Schäper, et al.
Drug Testing and Analysis|August 28, 2019
Detection of testosterone doping in female athletesDavid J Handelsman, Stéphane Bermon
Drug Testing and Analysis|March 24, 2017
'APAAN in the neck' - A reflection on some novel impurities found in seized materials containing amphetamine in Ireland during routine forensic analysisJohn D Power, Pierce Kavanagh, Gavin McLaughlin, et al.
Drug Testing and Analysis|March 26, 2017
Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS<sup>n</sup> , and LC-HR-MS/MSAchim T Caspar, Jonas B Gaab, Julian A Michely, et al.
Pageof 277